Exelixis, Inc.

A medial security in the Health Care that looks (login to see)

Yahoo! Profile

EXEL

Research and Development in Biotechnology
Weighting

Strong Growth

Lead | Lag

Medial

Options

Buying (0.67)

P/E Ratio

43.31

Free Cash Flow

Positive (0.18)

Dividend

none

Begin Today!

Have access to custom plans you can create, auto-portfolios and much more!




NO OBLIGATION TO BUY